Feed ROP.SW
RO
Roche Holding AG ROP.SW · SIX
CHF 378.30 -0.24% (-CHF 0.90)
Depth
- Market cap
- CHF 300.9B
- Enterprise value
- CHF 328.5B
- P/E
- 23.4x
- Forward P/E
- 18.6x
- PEG
- 0.4x
- P/S
- 4.9x
- P/FCF
- 21.4x
- EV/EBITDA
- 14.5x
- ROIC
- 20.3%
- Gross margin
- 73.5%
- Net margin
- 20.9%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 1.2x
- Beta
- 0.35
- Free float
- 86.5%
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Thomas Schinecker
Employees
103,249
Headquarters
Basel
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number